AURKA and glioblastoma: In the CGGA dataset, GBM patients with low-expressed AURKA had significantly favorable overall survival (OS) days compared with high-expression AURKA (95% confidence interval (CI), 2.488-5.020; hazard ratio (HR), 3.506; p<0.01) (Figure 3C).